Opexa Therapeutics (OPXA US)

Acer Therapeutics Inc. operates as a pharmaceutical company. The Company develops therapies for the treatment of ultra-rare diseases, vascular ehlers-danlos syndrome, and maple syrup urine diseases. Acer Therapeutics serves patients in the United States.